ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1379

Renal tubular acidosis in Sjögren’s disease and non-Sjögren’s sicca in an Oklahoma cohort

Biji T Kurien1, Martha Tsaliki2 and R Hal Scofield1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2OMRF, Oklahoma City, OK

Meeting: ACR Convergence 2025

Keywords: Autoantibody(ies), autoimmune diseases

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1376–1404) Sjögren’s Disease – Basic & Clinical Science Poster II: Clinical Manifestations and Health Outcomes

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Renal involvement in primary Sjögren’s disease (pSjD) is a well-known extraglandular manifestation with a prevalence of 5-14% in several studies. Mostly, it affects the renal tubules through tubulointerstitial nephritis, resembling lymphocytic infiltration in the exocrine glands. Distal renal tubular acidosis (RTA), rather than proximal RTA, is the most frequent tubular dysfunction in SjD. We hypothesized that RTA occurs in SjD and non-SjD sicca and will be found in those with high urinary pH, and that it will correlate with serum hypokalemia and bicarbonate.

Methods: We screened urinary and serum metabolic data from primary SjD, incomplete SjD, and healthy controls from the database maintained by Oklahoma Sjögren’s Syndrome Center of Research Translation at the Oklahoma Medical Research Foundation (OMRF). This work was part of a study approved by the Institutional Review Board of OMRF and the University of Oklahoma Health Sciences Center.

Results: We found data for urinary pH and metabolic profile in 504 pSjD, 725 incomplete Sjögren’s, and 13 healthy controls. Sixty pSjD, 115 non-Sjögren’s sicca subjects, and 2 healthy controls had a urinary pH greater than 7.5. Of these 23 SjD, 46 incomplete SjD and 1 healthy control had a pH greater than 8. Seven SjD subjects had a urinary pH of 8.5, while 2 had a pH of 9. Two each of incomplete Sjögren’s had a pH of 8.5 and 9. The 23 SjD subjects had a significantly higher alkaline pH compared to incomplete Sjögren’s (pH 8.24 ±0.275 Vs 8.06 ±0.224 respectively, p= 0.01). All the 60 pSjD or 115 non-Sjögren’s sicca subjects had a highly significant alkaline pH compared to healthy controls (p< 0.0001). However, very interestingly, there was no significant difference in bicarbonate, potassium, or chloride levels between the SjD, incomplete SjD, or the controls in subjects. Anion gap was within normal range in the SjD, non-Sjögren’s sicca, and healthy controls. While the SjD and non-Sjögren’s sicca subjects with highly alkaline urinary pH may have specific tubular defects that hinder urine acidification, the defects may not be severe enough to bring about RTA in our cohort.

Conclusion: Higher urinary pH is found in SjD compared to non-Sjögren’s sicca, and healthy controls. However, the defect in urine acidification does not appear to be related to RTA in our cohort.


Disclosures: B. Kurien: None; M. Tsaliki: None; R. Scofield: IQVIA, 1, Jannsen Pharmaceuticals, 1.

To cite this abstract in AMA style:

Kurien B, Tsaliki M, Scofield R. Renal tubular acidosis in Sjögren’s disease and non-Sjögren’s sicca in an Oklahoma cohort [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/renal-tubular-acidosis-in-sjogrens-disease-and-non-sjogrens-sicca-in-an-oklahoma-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/renal-tubular-acidosis-in-sjogrens-disease-and-non-sjogrens-sicca-in-an-oklahoma-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology